Xenometrix AG

Xenometrix AG is a Swiss biotechnology company specializing in the production, distribution, and provision of bioassays for in vitro toxicology, molecular pharmacology, and chemical screening. The company offers a wide range of standardized, ready-to-use kits—including miniaturized Ames test systems, endocrine disruptor assays, and skin absorption models—designed for industries such as pharmaceuticals, agrochemicals, cosmetics, and environmental protection. Its assay solutions are engineered to support drug discovery and regulatory compliance by providing high reproducibility, automation compatibility, and adherence to international guidelines like OECD and ICH M7.

Beyond product supply, Xenometrix provides specialized preclinical service analytics under GLP and non-GLP conditions. These services assist partners in assessing mutagenicity, genotoxicity, cytotoxicity, and dermal permeation using proprietary skin models. By serving over 300 customers globally, the company helps organizations accelerate safety evaluations and risk assessments while maintaining high quality standards certified by ISO 9001:2015. Through its expertise in cell biology and biochemistry, Xenometrix functions as a partner for research institutes and regulatory authorities requiring accurate, standardized toxicological data.